This article first appeared on GuruFocus. Tesla (NASDAQ:TSLA) is facing mounting legal pressure in Australia after a federal judge sharply criticized the company's handling of a class action lawsuit tied to alleged vehicle defects and self driving claims, adding to the growing global scrutiny around Tesla's safety technology. Shares of Tesla fell more than 4% after Australian federal court judge T...
This article first appeared on GuruFocus. Tesla (NASDAQ:TSLA) is facing mounting legal pressure in Australia after a federal judge sharply criticized the company's handling of a class action lawsuit tied to alleged vehicle defects and self driving claims, adding to the growing global scrutiny around Tesla's safety technology. Shares of Tesla fell more than 4% after Australian federal court judge Tom Thawley warned the company it could face a really bad time if what he described as inadequate cooperation with the lawsuit continued. The judge reportedly questioned whether Tesla had taken the legal process seriously at all, calling the scale of disclosures provided so far gobsmacking. The lawsuit, brought on behalf of roughly 10,000 Australian Tesla drivers, accuses the company of misleading consumers about phantom braking incidents, vehicle battery range and the capabilities of its self driving technology. Tesla has denied mischaracterizing its products and said it remains concerned about disclosing sensitive engineering data and internal information. But the court appeared frustrated with the pace of Tesla's document production during the discovery process. According to Reuters, Tesla has reportedly turned over only about 2,000 documents over eight months, while plaintiffs argued the company failed to provide enough engineering and complaint related records for experts to properly evaluate the claims. Tesla's legal team said the company manually reviewed around 100,000 documents and still had another 75,000 left to examine. The judge ordered Tesla to complete discovery by July 31 and scheduled another hearing for September 1. The lawsuit also arrives while Tesla continues facing broader regulatory scrutiny over its Full Self Driving technology in the United States. The National Highway Traffic Safety Administration has already expanded investigations into millions of Tesla vehicles tied to traffic violations and safety concerns involving the system.
Amazon (NASDAQ:AMZN) is starting to look like a real frontrunner in physical AI. Now, it’s no mystery that Amazon has been putting robots to work at its warehouse, behind the scenes, to help out humans with all those packages. But until you’ve seen the robots at work, it’s difficult to even begin to fathom what ... Amazon Has Over 1.56 Million Workers and 1 Million Robots. A Historic Robot vs. Hum...
Amazon (NASDAQ:AMZN) is starting to look like a real frontrunner in physical AI. Now, it’s no mystery that Amazon has been putting robots to work at its warehouse, behind the scenes, to help out humans with all those packages. But until you’ve seen the robots at work, it’s difficult to even begin to fathom what ... Amazon Has Over 1.56 Million Workers and 1 Million Robots. A Historic Robot vs. Human Contest Dropped a Hint on What Might Come Next.
Ondas ( ONDS ) stock is trading nearly 2% lower at $9.19 on Thursday even after the company confirmed via its X account and newly filed Form 8-K that it has officially closed the acquisition of Omnisys. On May 18, Ondas announced that it had entered into a definitive agreement to acquire 100% of Omnisys, an Israeli developer of AI-powered BRO software used for multi-domain defense planning and rea...
Ondas ( ONDS ) stock is trading nearly 2% lower at $9.19 on Thursday even after the company confirmed via its X account and newly filed Form 8-K that it has officially closed the acquisition of Omnisys. On May 18, Ondas announced that it had entered into a definitive agreement to acquire 100% of Omnisys, an Israeli developer of AI-powered BRO software used for multi-domain defense planning and real-time battlefield decision-making. Today, the company confirmed the acquisition has closed, marking a key step in Ondas’ transition into a software-defined defense technology company. Under the agreement, the firm acquired all outstanding shares of Omnisys in a stock deal valued at about $196.6M. The company issued around 3.1M shares at closing, including shares placed in escrow, while the remaining consideration will be paid in additional Ondas common stock through scheduled installments. The company said Omnisys is expected to contribute more than $100M in revenue across 2026 and 2027 while adding a high-margin software business to its platform. Moreover, Omnisys’ BRO mission software is now integrated into the company's systems-of-systems architecture, helping coordinate missions across sensors, autonomous systems, and defense assets operating in complex battlefield environments. Despite the strategic update, ONDS stock is down around ~13% over the past week. On a YTD basis, the stock has returned -4.20%, compared with an 8.58% gain for the S&P 500 ( SP500 ) price return . Investors should note that the Quant Ratings and Wall Street analysts currently maintain a Strong Buy rating on the stock with a 4.84 score. More on Ondas Ondas Inc. 2026 Q1 - Results - Earnings Call Presentation Ondas Inc. (ONDS) Q1 2026 Earnings Call Transcript Ondas: The Bears Forgot One Thing Ondas to buy defense software firm Omnisys Ondas targets at least $390M 2026 revenue as backlog rises to over $450M following World View and Mistral deals
ZKH Group press release ( ZKH ): Q1 GAAP EPS of RMB0.06. Revenue of RMB2.11M. More on ZKH Group Seeking Alpha’s Quant Rating on ZKH Group Historical earnings data for ZKH Group
ZKH Group press release ( ZKH ): Q1 GAAP EPS of RMB0.06. Revenue of RMB2.11M. More on ZKH Group Seeking Alpha’s Quant Rating on ZKH Group Historical earnings data for ZKH Group
总部位于洛杉矶的空中出行平台企业Surf Air Mobility宣布,公司首席执行官Deanna White和首席财务官Oliver Reeves将于2026年6月8日出席Jefferies创新航空航天虚拟峰会,并进行专题演讲。 Surf Air Mobility通过其AI驱动的SurfOS软件,致力于推动航空运营现代化和下一代飞机的应用。公司目前运营着美国最大的通勤航空公司之一,按定期航班起降...
总部位于洛杉矶的空中出行平台企业Surf Air Mobility宣布,公司首席执行官Deanna White和首席财务官Oliver Reeves将于2026年6月8日出席Jefferies创新航空航天虚拟峰会,并进行专题演讲。 Surf Air Mobility通过其AI驱动的SurfOS软件,致力于推动航空运营现代化和下一代飞机的应用。公司目前运营着美国最大的通勤航空公司之一,按定期航班起降量计算位居前列,同时提供私人包机服务。 此次峰会为行业专业人士和投资者提供了一个了解航空业发展趋势的平台。作为区域航空出行领域的重要参与者,Surf Air Mobility正积极推进电气化战略。今年3月,公司与BETA Technologies达成战略合作,订购了25架全电动ALIA飞机,并拥有追加75架的期权,计划成为首家将电动客机投入商业运营的135部运营商。 投资者如需与公司安排会议,可通过Jefferies代表或发送邮件至指定邮箱联系。峰会上的演讲内容预计将涉及公司区域航空业务拓展、AI技术应用及电动飞机商业化进展等战略方向。 责任编辑:张俊 SF065
This article first appeared on GuruFocus. Apple (AAPL, Financials) has reduced prices on several iPhone 17 models in China ahead of the country's major 618 shopping event next month. According to listings on JD.com and Alibaba's Taobao platform, some iPhone 17 Pro models received discounts of up to 1,000 yuan, or about $138. With trade-in offers and additional promotions, the starting price for ce...
This article first appeared on GuruFocus. Apple (AAPL, Financials) has reduced prices on several iPhone 17 models in China ahead of the country's major 618 shopping event next month. According to listings on JD.com and Alibaba's Taobao platform, some iPhone 17 Pro models received discounts of up to 1,000 yuan, or about $138. With trade-in offers and additional promotions, the starting price for certain Pro models dropped to 6,999 yuan. The base iPhone 17 lineup also saw price cuts as Apple looks to stay competitive in China's crowded smartphone market. Rival brands including Huawei and Xiaomi have also rolled out promotions ahead of the shopping holiday. China's government trade-in subsidy program has also helped reduce smartphone prices for consumers, adding more pressure across the market. For Apple, the discounts highlight how important China remains for iPhone sales as local brands continue gaining ground.
This article first appeared on GuruFocus. Bill Ackman (Trades, Portfolio) is betting that Microsoft's pullback may have created a window for investors, with Pershing Square building a new core position in Microsoft (NASDAQ:MSFT) after the company's shares fell 15% this year through Thursday's close. Ackman said Pershing began buying in February and will disclose the stake in a regulatory filing Fr...
This article first appeared on GuruFocus. Bill Ackman (Trades, Portfolio) is betting that Microsoft's pullback may have created a window for investors, with Pershing Square building a new core position in Microsoft (NASDAQ:MSFT) after the company's shares fell 15% this year through Thursday's close. Ackman said Pershing began buying in February and will disclose the stake in a regulatory filing Friday, describing Microsoft's 365 suite and Azure cloud service as two of the most valuable franchises in enterprise technology. Microsoft shares rose 2.9% to $421.40 late Friday morning in New York after Ackman revealed the position on X, suggesting investors were paying close attention to Pershing's latest move into big tech. Ackman's argument centers on the idea that Microsoft may be stronger and more durable than the market currently reflects. He said 365 products such as Word and Excel are deeply embedded across large companies and supported by infrastructure that may be nearly impossible to replicate, while Azure's demand could make concerns about its growth look misplaced. The investment comes as Microsoft faces questions over Copilot adoption, competition around its 365 business and whether the company can add enough data center capacity to meet cloud demand. Ackman also pointed to LinkedIn and Xbox as leading businesses beyond Microsoft's core software and cloud franchises. The move also appears to come alongside a possible shift in Pershing's exposure to Alphabet (NASDAQ:GOOG). Ackman said he had sold Google, though he did not say how much of the remaining stake was sold or whether it was a new sale, after filings showed Pershing had already sold down most of its Alphabet position in December. Pershing still has sizeable stakes in Amazon.com (NASDAQ:AMZN) and Meta Platforms (NASDAQ:META), where Ackman has previously made similar arguments that investors may be underestimating long-term upside tied to AI or cloud recovery. For investors, the message is direct: Ackma...
AlexSecret/iStock via Getty Images Written by Nick Ackerman, co-produced by Stanford Chemist The Guggenheim Active Allocation Fund ( GUG ) provides investors with a diversified exposure to investment securities. While the fund has the flexibility to be quite active in its approach to asset allocation, the fund has largely remained invested in fixed-income instruments. That perhaps isn't all that s...
AlexSecret/iStock via Getty Images Written by Nick Ackerman, co-produced by Stanford Chemist The Guggenheim Active Allocation Fund ( GUG ) provides investors with a diversified exposure to investment securities. While the fund has the flexibility to be quite active in its approach to asset allocation, the fund has largely remained invested in fixed-income instruments. That perhaps isn't all that surprising, given that the fund sponsor is known as a fixed-income asset manager. The fund's discount has narrowed quite materially over the last ~6 months, reducing its relative appeal as it comes less attractively valued. GUG Basics 1-Year Z-score: 1.33 Discount/Premium: -4.65% Distribution Yield: 9.13% Expense Ratio: 1.80% (3.27% including leverage) Leverage: 24.47% Managed Assets: $717 million Structure: Term (anticipated liquidation date of November 22, 2033) GUG's investment objective is "to maximize total return through a combination of current income and capital appreciation." To achieve this, the fund will... ...pursue both a tactical asset allocation strategy, dynamically allocating across asset classes, and a relative value-based investment strategy, utilizing quantitative and qualitative analysis to seek to identify securities with attractive relative value and risk/reward characteristics. In doing this, the fund's "sub-adviser seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies." Performance To GOF GUG has delivered positive total returns since our prior update , though some of that has come from discount narrowing. At the same time, it has still fallen a bit short of what the S&P 500 Index has delivered during this period. GUG Performance Since Prior Update (Seeking Alpha) That isn't necessarily the worst, as this fund is more heavily tilted toward fixed-income investments, despite its overall hybrid approach. This has generally been the case since I've been covering the fun...
Jonathan Kitchen/DigitalVision via Getty Images Investors Should Know: Even while some major tech firms cut staff as part of their AI development strategy, adoption of the technology is often limited for reasons related to human resources. Internal talent gaps, labor cost pressure, and shifting commercial models are shaping how companies make their AI investment decisions. This puts AI technology ...
Jonathan Kitchen/DigitalVision via Getty Images Investors Should Know: Even while some major tech firms cut staff as part of their AI development strategy, adoption of the technology is often limited for reasons related to human resources. Internal talent gaps, labor cost pressure, and shifting commercial models are shaping how companies make their AI investment decisions. This puts AI technology companies in the spotlight, as companies look for ways to optimize their workforces. Background Last week, Cisco ( CSCO ) became the latest high-profile tech player to announce job cuts related to its AI strategy. The firm joins a list that includes Amazon ( AMZN ), Meta ( META ), and Block ( XYZ ). Still, the staffing story as it relates to AI is more complicated than just replacing human workers with machines. Large-scale tech giants are trimming their workforces in the face of AI's productivity promise. But smaller firms are having trouble finding the right people. According to a recent study of mid-market firms, the most commonly cited barrier to expanding AI adoption is a "lack of internal expertise," alongside labor costs and talent gaps. Organizations are prioritizing AI and digital transformation, but workforce readiness is a gating factor. While companies scramble to optimize their workforces and bring in the right people, companies closely related to the AI buildout are working to push the technology forward. How these processes intersect could dictate the future of the workforce. Key publicly traded companies aligned with the AI and machine learning theme include Nebius Group N.V. ( NBIS ) and Advanced Micro Devices, Inc. ( AMD ) as core infrastructure and compute players. Twilio Inc. ( TWLO ), SentinelOne, Inc. ( S ), Arista Networks, Inc. ( ANET ), and Autodesk, Inc. ( ADSK ) represent direct exposure across cloud communications, cybersecurity, networking, and design software. Innodata Inc. ( INOD ) and Kingsoft Cloud Holdings Limited ( KC ) round out the thema...
AMD's EPYC Venice CPUs have entered volume production, making them the first HPC product to achieve the milestone on TSMC's 2nm process tech. AMD & TSMC Enter Volume Production On The Industry's First 2nm HPC Chip, 6th Gen EPYC Venice The Agentic AI boom is driving the CPU market up, unlike anything that came before. High-Performance CPUs are seeing massive demands, and AMD, being a leader in HPC,...
AMD's EPYC Venice CPUs have entered volume production, making them the first HPC product to achieve the milestone on TSMC's 2nm process tech. AMD & TSMC Enter Volume Production On The Industry's First 2nm HPC Chip, 6th Gen EPYC Venice The Agentic AI boom is driving the CPU market up, unlike anything that came before. High-Performance CPUs are seeing massive demands, and AMD, being a leader in HPC, has just achieved volume ramp of its next-generation EPYC Venice CPUs based on the Zen 6 core architecture. The volume ramp was achieved on TSMC's cutting-edge 2nm process technology. Image Source: AMD Looking ahead, AMD plans to achieve volume ramp for the same EPYC Venice CPUs at TSMC Arizona, further enhancing its manufacturing capacity to fulfill the demands of AI datacenters and Enterprises. AMD will also extend TSMC's 2nm process technology to its next-generation "AI-Focused" CPU called Verano, which is a version of Venice designed specifically for Agentic AI workflows and features the latest memory standards, such as LPDDR, providing the performance, bandwidth, and efficiency advantage for AI. AMD and TSMC’s partnership spans the technologies needed to scale modern data center computing, from TSMC 2nm process technology for next-generation CPUs to advanced packaging technologies, including TSMC’s SoIC-X and CoWoS-L, used across AMD’s broader AI and data center portfolio. With “Venice” ramping on TSMC 2nm, AMD is advancing the CPU foundation for AI infrastructure while continuing to leverage TSMC’s process and packaging leadership to deliver increasingly integrated compute platforms at scale. AMD What We Know About AMD's EPYC Venice CPUs So Far The 6th Gen AMD EPYC family will be codenamed Venice, and will feature the Zen 6 core architecture. AMD's EPYC Venice CPUs will offer over 70% improvement in performance and efficiency. This is quite massive and shows us what Zen 6 is capable of, even if this lineup only represents the server segment. In addition to the perfor...
The Good Brigade/DigitalVision via Getty Images e.l.f. Beauty ( ELF ) shares lifted 9% after reporting Q4 earnings on May 20. The $3.3 billion market cap Consumer Discretionary name has been a major laggard in the US market over the past year, hammered by a series of post-earnings declines. Weakness in health & beauty care spending has weighed, along with other macro factors. But shares are attrac...
The Good Brigade/DigitalVision via Getty Images e.l.f. Beauty ( ELF ) shares lifted 9% after reporting Q4 earnings on May 20. The $3.3 billion market cap Consumer Discretionary name has been a major laggard in the US market over the past year, hammered by a series of post-earnings declines. Weakness in health & beauty care spending has weighed, along with other macro factors. But shares are attractive on valuation. Today, with Q1 numbers in hand, I reiterate a buy rating. ELF trades with a sporty mid-teens price-to-earnings ratio, while technical support came about right where I imagined it would. Back in November , I was upbeat fundamentally on ELF, but the stock tumbled 25% to today. I outlined a bearish technical thesis that, unfortunately for stockholders, came to fruition. ELF: Shares Fell Sharply From September to May Stockcharts.com In May, ELF reported a solid set of quarterly results. Fiscal Q4 non-GAAP EPS of $0.32 topped the Wall Street consensus forecast of $0.29, while revenue of $449 million, up more than 35% from the same period a year earlier, was a material $27 million beat. The company issued robust guidance , with fiscal 2027 revenue seen between $1.835 and $1.865 billion, a modest raise. Bigger picture, FY 2026 marked a year of 25% top-line growth, with ELF gaining 115bps in US market share. Recent profitability has been stung by margin pressure due to increased market spend and tariffs. Shares launched 9% by the following morning and as of this writing. If that gain holds to the close, it would mark the first post-reporting climb since May 2025. For perspective, the options market had priced in a high 13.7% earnings-related stock price swing based on the at-the-money straddle expiring soonest after the release, while implied volatility on the Household & Personal Products industry company equity was near 100% leading into the earnings event. Adding to potential upside fuel is a high 12.4% short interest. Looking back on the quarter that was, ELF...
Is It Ok To Want My Investments To Go To Zero So Yield Can Go To Infinity? Klaus Vedfelt/DigitalVision via Getty Images Oxford Lane Capital ( OXLC ) has been one of our favorite funds to write about. The main reason we have enjoyed the process has little to do with the returns of the fund. It also has nothing to do with ownership either , as we have not owned the common units. No, the fun aspect h...
Is It Ok To Want My Investments To Go To Zero So Yield Can Go To Infinity? Klaus Vedfelt/DigitalVision via Getty Images Oxford Lane Capital ( OXLC ) has been one of our favorite funds to write about. The main reason we have enjoyed the process has little to do with the returns of the fund. It also has nothing to do with ownership either , as we have not owned the common units. No, the fun aspect has been the opportunity to dive into human psyche in the comments that followed. Cognitive dissonance, sunk cost fallacy, and defense of indefensible, were all part of the pay package for us. We go over the recent results and look at why the suffering has not stopped. Q4-2026 OXLC's fiscal year ends on March 31. The most recently announced results were for Q4-2026. The "financial highlights" slide captured a lot of what has happened to the fund over the last 12 months. The first thing we would focus on is the drop in NAV which was close to 50% over this timeframe. The most recent drop from $15.51 to $10.56 was also the fastest percentage decline. OXLC Presentation Those are the kind of numbers that make absolutely everything else irrelevant. What stands us out to us here is the fact that OXLC still keeps showing the Core Net Investment Income as if it has any meaning. What is hilarious though, is that OXLC distribution does not even appear to be covered in any of the last 5 quarters, by its favorite metric. Of course the new distribution is now 60 cents a quarter and on the surface, appears to be "covered". What we want to highlight here is that OXLC is running a far riskier setup than what it did 12 months back. We are referring to total leverage (counting preferreds as leverage as well) to total assets ratio. You can see that below. In Q4-2025 this ratio was at 28.5%. OXLC Presentation As of March 31, 2026, we are at 46%. Sure, it is a bit higher if you take the April numbers (which management mentioned in their press release). But what this appears to us is an extremely ...
synthetick/iStock via Getty Images Definium Therapeutics' ( DFTX ) stock continues to lead its psychedelic peers, which potentially stems from the fact that the company has a relatively broad pipeline and expects a number of pivotal data readouts in the next 12 months. Top line data from the Emerge MDD trial is expected in the second quarter and the Phase III readout for GAD is expected in Q3. Pos...
synthetick/iStock via Getty Images Definium Therapeutics' ( DFTX ) stock continues to lead its psychedelic peers, which potentially stems from the fact that the company has a relatively broad pipeline and expects a number of pivotal data readouts in the next 12 months. Top line data from the Emerge MDD trial is expected in the second quarter and the Phase III readout for GAD is expected in Q3. Positive trial data would lead to NDA submission for DT120 ODT, and while nothing is guaranteed at this point, there is a lot of data supporting the use of LSD to treat psychiatric conditions. In addition, the President's recent executive order could help to provide a smooth path to market for psychedelics. The large increase in Definium's share price over the past 12 months calls into question the strength of near-term returns. I tend to think Definium will still offer reasonable returns though, even if the stock is now likely to tread water until the release of clinical data. Market While Definium Therapeutics is targeting a broader range of conditions than most of its psychedelic peers, its phase III trials of LSD for GAD (Generalized Anxiety Disorder) and MDD (Major Depressive Disorder) are the most advanced, making these more relevant to the share price in the near-term. MDD is characterized by persistent feelings of sadness or a lack of interest in daily life. Patients can also exhibit physical symptoms, like fatigue and changed appetite. To be clinically diagnosed, patients must exhibit symptoms for more than 2 weeks. GAD is characterized by persistent and excessive stress, even when there is no apparent cause for concern. There are a number of existing treatments for these conditions that are broadly adopted and in many cases generate a large amount of revenue. Figure 1: Revenue from Existing Therapies ( Source: Definium Therapeutics) There is still a significant unmet need though as these treatments have poor efficacy and tolerability. As a result, discontinuation rat...
Tom Werner/DigitalVision via Getty Images Potential sale thesis around the corner ITGR is the sole publicly traded medical device CDMO, a rare asset by any standard and one that has been far more popular in private markets than in public. Integer is the largest outsourced manufacturing partner for the major device OEMs. The company operates in high-growth, sticky end markets with high switching co...
Tom Werner/DigitalVision via Getty Images Potential sale thesis around the corner ITGR is the sole publicly traded medical device CDMO, a rare asset by any standard and one that has been far more popular in private markets than in public. Integer is the largest outsourced manufacturing partner for the major device OEMs. The company operates in high-growth, sticky end markets with high switching costs due to deep regulatory entrenchment. Despite this quality, the company trades at just 10x EBITDA, driven by a massive sell-off on temporary revenue slowdown expected to be fully normalized by 2027. Based on precedent transaction multiples, I believe fair value is around 110-125, or around 20-40% upside from current levels. More details on the valuation below. There is another kicker to this thesis that makes the fundamental story even more attractive. With no public comps, the company suffers from limited investor and analyst understanding. Public investors simply don't have the information needed to properly analyze the business. A private buyer under a confidentiality agreement would be able to carry out due diligence on Integer's products, contracts, and pipeline in full detail, underwriting future growth with far greater confidence. Fortunately for shareholders, the company announced a strategic review just a few weeks ago. There is a decent chance the potential sale will serve as a key catalyst for the stock over the next few months. Let's unpack. The review was announced in light of heightened interest from multiple parties, meaning there are potentially bidders already working on a deal behind closed doors. This is a far better starting point than a strategic review with a broad and unclear direction. Quote from Bank of America Global Healthcare Conference 2026 (May 12): Integer, as a leader in this space, has always had interest from other parties. That interest has been heightened in recent months. We've had a relatively large number of parties that have expres...
Board of Directors member Keith A. Meister reported the purchase of 351,273 shares of GeneDx (WGS +6.10%) across multiple open-market transactions from May 13 to May 15, 2026, at a weighted average price of $39.19 per share, as disclosed in this SEC Form 4 filing. Transaction summary Metric Value Shares traded (indirect) 351,273 Transaction value $13.8 million Post-transaction shares (direct) 20,1...
Board of Directors member Keith A. Meister reported the purchase of 351,273 shares of GeneDx (WGS +6.10%) across multiple open-market transactions from May 13 to May 15, 2026, at a weighted average price of $39.19 per share, as disclosed in this SEC Form 4 filing. Transaction summary Metric Value Shares traded (indirect) 351,273 Transaction value $13.8 million Post-transaction shares (direct) 20,129 Post-transaction value (direct ownership) ~$789,000 Transaction and post-transaction values based on SEC Form 4 weighted average purchase price ($39.19). Key questions How does the purchase size compare to Meister's historical trading activity? The 351,273-share acquisition is one of the larger transactions in Meister's history, though the historical cadence reflects infrequent open-market buys, with just over four trades per year and a prior single sell transaction of 883,742 shares. The 351,273-share acquisition is one of the larger transactions in Meister's history, though the historical cadence reflects infrequent open-market buys, with just over four trades per year and a prior single sell transaction of 883,742 shares. What is the structure of Meister's ownership post-transaction? Post-transaction, direct ownership stands at 20,129 shares, while indirect holdings total 5,117,714 shares, primarily managed via Corvex Management LP and CMLS Holdings LLC, as detailed in the filing. Post-transaction, direct ownership stands at 20,129 shares, while indirect holdings total 5,117,714 shares, primarily managed via Corvex Management LP and CMLS Holdings LLC, as detailed in the filing. What percentage of Meister's holdings did this transaction represent, and how does it affect his capacity for future trades? This purchase represented 7.34% of Meister's total holdings at the time, but with direct holdings now comprising only a small fraction of total beneficial ownership, future large-scale purchases would require increased capacity or new share issuances. This purchase repres...
That Queen Elizabeth II was “very keen” for Andrew Mountbatten-Windsor to take on a “prominent role in the promotion of national interests” as a trade envoy in 2001 demonstrates the fierce support the late monarch always gave her second son. Knowing he was “the spare”, and undoubtedly acutely aware of the pitfalls of that position – her sister, Princess Margaret, had struggled to find her own role...
That Queen Elizabeth II was “very keen” for Andrew Mountbatten-Windsor to take on a “prominent role in the promotion of national interests” as a trade envoy in 2001 demonstrates the fierce support the late monarch always gave her second son. Knowing he was “the spare”, and undoubtedly acutely aware of the pitfalls of that position – her sister, Princess Margaret, had struggled to find her own role – a mother’s instinct would be to protect, so far as she could. Presumably, she believed it would give the then Prince Andrew structure and purpose as he was steadily bumped down the line of succession, as well as highlighting the family’s own royal brand of usefulness to the country. After a Royal Navy career, during which he even briefly enjoyed “national hero” status, posing with a rose on his return from combat in the Falklands, it could offer him direction away from the luxury yacht parties and golf courses. How wrong she was. Royal commentators have long espoused the theory that when it came to Andrew, the late queen was blinkered. It is rumoured he was her favourite son. Perhaps he was. What is quite evident, however, is that he was the first of her four children she was able to spend more time with as infants. When Charles and Anne were born, she was undertaking many engagements on behalf of her ailing father, George VI. On his death, she was dealing with the stresses of being a young mother and a monarch. Overseas engagements kept her away from the royal nursery for extended periods. When Andrew was born, having settled into her position she was able to spend more time with him, cutting back on evening engagements, sometimes taking charge of bedtimes. A closer maternal bond, perhaps, was formed with Andrew and then his brother Edward. As he grew older, it was evident, too, that the former Duke of York’s character was very different to that of his older brother, Charles. He was, according to the royal biographer Robert Hardman, “not as bright as the others, he coul...
TSLA stock is moving. See the chart and price action here. Ives made the call in a Wednesday note after SpaceX officially filed its S-1 to go public, a move Wedbush called the largest IPO in stock market history and a "major moment" for space and tech. The analyst also repeated the merger view during an appearance on Anthony Pompliano's podcast, saying the odds of a Tesla-SpaceX combination are no...
TSLA stock is moving. See the chart and price action here. Ives made the call in a Wednesday note after SpaceX officially filed its S-1 to go public, a move Wedbush called the largest IPO in stock market history and a "major moment" for space and tech. The analyst also repeated the merger view during an appearance on Anthony Pompliano's podcast, saying the odds of a Tesla-SpaceX combination are now about 80%. Wedbush expects the two Musk-led companies to merge in 2027 after the SpaceX IPO, arguing that the connective tissue between the businesses is already being built. The firm pointed to Tesla's existing stake in SpaceX, which resulted from Tesla's $2 billion investment in xAI being converted into SpaceX shares following SpaceX's acquisition of xAI earlier this year. While that stake represents less than 1% of SpaceX's expected valuation, Wedbush said it marks an important structural link. Musk's AI Ecosystem The bigger strategic rationale, in Ives' view, is artificial intelligence. SpaceX's S-1 lays out a $28.5 trillion total addressable market (TAM) spanning space-enabled solutions, connectivity and AI, including $22.7 trillion in enterprise applications. The filing also highlights SpaceX's push to own more of the physical AI compute stack, including planned V3 satellites in the second half of 2026 and solar-powered AI compute satellites by 2028. Wedbush said the recently announced joint Terafab facility between Tesla and SpaceX further strengthens the case by creating operational overlap. Ives framed the potential combination as part of Musk's broader push to control more of the AI ecosystem. Tesla brings manufacturing scale, energy storage, robotics and vehicle data, while SpaceX adds satellite infrastructure, Starlink connectivity and xAI's Grok platform. "Musk wants to own and control more of the AI ecosystem," Ives wrote, adding that the "holy grail" could be combining SpaceX and Tesla "in some way" to create deeper connective tissue between two disruptive ...